cytrx.com
About cytrx.com
CytRx Corporation (NASDAQ: CYTR), located in Los Angeles, California, is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics. CytRx’s drug development pipeline includes two product candidates in clinical development for cancer indications, including a registration clinical trial of tamibarotene for the treatment of acute promyelocytic leukemia, or APL.
